» Articles » PMID: 33651624

Rapid Identification of Inhibitors and Prediction of Ligand Selectivity for Multiple Proteins: Application to Protein Kinases

Overview
Journal J Phys Chem B
Specialty Chemistry
Date 2021 Mar 2
PMID 33651624
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Rapid identification of inhibitors for a family of proteins and prediction of ligand specificity are highly desirable for structure-based drug design. However, sequentially docking ligands into each protein target with conventional single-target docking methods is too computationally expensive to achieve these two goals, especially when the number of the targets is large. In this work, we use an efficient ensemble docking algorithm for simultaneous docking of ligands against multiple protein targets. We use protein kinases, a family of proteins that are highly important for many cellular processes and for rational drug design, as an example to demonstrate the feasibility of investigating ligand selectivity with this algorithm. Specifically, 14 human protein kinases were selected. First, native docking calculations were performed to test the ability of our energy scoring function to reproduce the experimentally determined structures of the ligand-protein kinase complexes. Next, cross-docking calculations were conducted using our ensemble docking algorithm to study ligand selectivity, based on the assumption that the native target of an inhibitor should have a more negative (i.e., favorable) energy score than the non-native targets. Staurosporine and Gleevec were studied as examples of nonselective and selective binding, respectively. Virtual ligand screening was also performed against five protein kinases that have at least seven known inhibitors. Our quantitative analysis of the results showed that the ensemble algorithm can be effective on screening for inhibitors and investigating their selectivities for multiple target proteins.

Citing Articles

Docking strategies for predicting protein-ligand interactions and their application to structure-based drug design.

Ma Z, Ajibade A, Zou X Commun Inf Syst. 2024; 24(3):199-230.

PMID: 39584017 PMC: 11583305. DOI: 10.4310/cis.241021221101.


Zebrafish as model system for the biological characterization of CK1 inhibitors.

Meier L, Gahr B, Roth A, Gihring A, Kirschner S, Woitaske-Proske C Front Pharmacol. 2023; 14:1245246.

PMID: 37753113 PMC: 10518421. DOI: 10.3389/fphar.2023.1245246.

References
1.
Slynko I, Scharfe M, Rumpf T, Eib J, Metzger E, Schule R . Virtual screening of PRK1 inhibitors: ensemble docking, rescoring using binding free energy calculation and QSAR model development. J Chem Inf Model. 2014; 54(1):138-50. DOI: 10.1021/ci400628q. View

2.
Notredame C, Higgins D, Heringa J . T-Coffee: A novel method for fast and accurate multiple sequence alignment. J Mol Biol. 2000; 302(1):205-17. DOI: 10.1006/jmbi.2000.4042. View

3.
Lahiry P, Torkamani A, Schork N, Hegele R . Kinase mutations in human disease: interpreting genotype-phenotype relationships. Nat Rev Genet. 2009; 11(1):60-74. DOI: 10.1038/nrg2707. View

4.
Cohen P . Protein kinases--the major drug targets of the twenty-first century?. Nat Rev Drug Discov. 2002; 1(4):309-15. DOI: 10.1038/nrd773. View

5.
Yan C, Grinter S, Merideth B, Ma Z, Zou X . Iterative Knowledge-Based Scoring Functions Derived from Rigid and Flexible Decoy Structures: Evaluation with the 2013 and 2014 CSAR Benchmarks. J Chem Inf Model. 2015; 56(6):1013-21. PMC: 5130226. DOI: 10.1021/acs.jcim.5b00504. View